Font Size: a A A
Keyword [Diffuse large]
Result: 21 - 40 | Page: 2 of 10
21. Characteristics Of IgVH Gene Structure In Small B-cell Lymphomas And Diffuse Large B-cell Lymphomas
22. Clinical Analysis Of 18 Cases With Refractory And Relapsed Diffuse Large B-Cell Lymphoma Treated With R-CHOP Regimen
23. Researching Pathology Classification And Prognosis Of B-cell Non-Hodgkin Lymphoma Using ProteinChip Technology
24. The Study On The Relation Of IRF4 Expression And Prognostic Value In Patients With Diffuse Large B-cell Lymphoma
25. The Significance Of The Detection Of Bcl-6, CD10, MUM-1 Expression And Bcl-2 Gene Rearrangement In Diffuse Large B Cell Lymphoma
26. Clinical Significance Of The Expression Of Skp2, P27 And Ki67 In Diffuse Large B-Cell Lymphoma
27. Expression And Clinical Significance Of BCL-2 And NF-κB/p65 In Diffuse Large B-cell Lymphoma
28. Identification Of Different Protein Expression Related To Diffuse Large B-cell Lymphoma Using SELDI Proteinchip Technique
29. Prognostic Factors In Diffuse Large B Cell Lymphoma, A Preliminary Study
30. An Observation Of The Therapeutic Effects With R-CHOP Regimen In Diffuse Large B-cell Lymphoma
31. Investigation Of Protein Expression In Follicular Lymphoma And Diffuse Large B-cell Lymphoma
32. Use ISH And FISH To Research The Relation Among Extranodal Diffuse Large B Cell Lymphoma, Epstein Barr Virus And Gene Abnormality
33. Study On Improper Modification Of Histone Acetylation, Methylation And Alteration Of Regulating Cell Cycle In Diffuse Large B-cell Lymphoma
34. The Expression And Significance Of CARD11, Bcl-2 And NF-κB In Diffuse Large B-cell Lymphoma
35. Dendritic Cells Derived From Lymphoma Cells Transduced By Recombinant Adenovirus Encoding Human P53 Elicit Potent Anti-tumour Immunse Response
36. Clinical Significance Of The Expression Of P53 And P16 In Diffuse Large B-Cell Lymphoma
37. Clinical Investigation Of Rituximab In Combination With CHOP Chemotherapy For Diffuse Large B Cell Lymphoma
38. Clinical Characteristics And Analysis Of Prognosis For 73 Patients With â… -â…¡ Stage Diffuse Large B-cell Lymphoma
39. Expression Of NF-κＢP50 And VEGF In Diffuse Large B-cell Lymphoma And Their Clinical Significance
40. Study On The Treatment With Chemotherapy Or Immuno-chemotherapy For The Patients With Diffuse Large B Cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to